Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (£272m) over five years because of Washington's demand for confidential data.
This rejection came to light following a government memo from December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official representative has since stated that the United States was demanding access to biological samples for research and profit while refused to share the benefits from any future treatments.
"We are forced to start the difficult and regrettable task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for more talks to secure a deal acceptable to both sides so the country's vital HIV programme can proceed.
Broader Context
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court halted a related deal with the US after concerns were filed about the safety of citizens' health data.
After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral agreements to boost openness and responsibility.
Based on statements, Sixteen nations in Africa have to date agreed to these new health pacts, constituting over $18.3bn of fresh investment.
Details of the Declined Deal
The money for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment through American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"In essence, our nation would provide the raw materials for medical research without any assurance that the end products would be available to our population should a future pandemic emerge."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting frameworks previously established through the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage future global health emergencies.
"This mechanism is intended to guarantee that when a country provides its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how future co-operation might be designed in a manner that honours the sovereignty and interests of each country."
Health Experts Response
A leading public health body stated it acknowledged the official position, but urged that talks need to persist given that much of the nation's Aids initiatives depended on foreign aid.
"In cases where technical issues exist, including those involving information security or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," the group commented.
The halted deal underscores the complex challenges between accepting crucial foreign assistance and safeguarding local interests in an ever more data-driven world.